+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)
Daiichi Sankyo Co Ltd - logo

Daiichi Sankyo is a global pharmaceutical company and one of the largest pharmaceutical company in Japan. The company offers therapies in the areas of hypertension, dyslipidemia, diabetes, acute coronary syndrome, metastatic melanoma, cardiology, oncology, pain, and others. Formerly known as Sankyo Pharma, it changed its name to Daiichi Sankyo in April 2006. The company was founded in 1996 and is based in Parsippany, New Jersey.

Ketolides Market Report 2025 - Product Thumbnail Image

Ketolides Market Report 2025

  • Report
  • March 2025
  • 200 Pages
  • Global
From
Antibiotic Resistance Market Report 2025 - Product Thumbnail Image

Antibiotic Resistance Market Report 2025

  • Report
  • February 2025
  • 200 Pages
  • Global
From
Antibiotics Market Report 2025 - Product Thumbnail Image

Antibiotics Market Report 2025

  • Report
  • February 2025
  • 200 Pages
  • Global
From
Non-Opioid Pain Patch Market Report 2025 - Product Thumbnail Image

Non-Opioid Pain Patch Market Report 2025

  • Report
  • February 2025
  • 200 Pages
  • Global
From
From
From
Topoisomerase Inhibitors - Pipeline Insight, 2025 - Product Thumbnail Image

Topoisomerase Inhibitors - Pipeline Insight, 2025

  • Clinical Trials
  • April 2025
  • 90 Pages
  • Global
From
Dyslipidemia Drugs - Global Strategic Business Report - Product Thumbnail Image

Dyslipidemia Drugs - Global Strategic Business Report

  • Report
  • June 2025
  • 268 Pages
  • Global
From
From
Metastatic Breast Cancer - Pipeline Insight, 2025 - Product Thumbnail Image

Metastatic Breast Cancer - Pipeline Insight, 2025

  • Drug Pipelines
  • April 2025
  • 100 Pages
  • Global
From
From
Cardiotonic Agents - Global Strategic Business Report - Product Thumbnail Image

Cardiotonic Agents - Global Strategic Business Report

  • Report
  • June 2025
  • 568 Pages
  • Global
From
Anti-Hypertensive Drugs - Global Strategic Business Report - Product Thumbnail Image

Anti-Hypertensive Drugs - Global Strategic Business Report

  • Report
  • June 2025
  • 326 Pages
  • Global
From
Acute Coronary Syndrome - Global Strategic Business Report - Product Thumbnail Image

Acute Coronary Syndrome - Global Strategic Business Report

  • Report
  • June 2025
  • 182 Pages
  • Global
From
From
Hemorrhagic Stroke Drugs - Global Strategic Business Report - Product Thumbnail Image

Hemorrhagic Stroke Drugs - Global Strategic Business Report

  • Report
  • June 2025
  • 287 Pages
  • Global
From
Thrombosis Drugs - Global Strategic Business Report - Product Thumbnail Image

Thrombosis Drugs - Global Strategic Business Report

  • Report
  • June 2025
  • 387 Pages
  • Global
From
Loading Indicator